Article

Synergistic Effects of Fructose and Food Preservatives on Non-Alcoholic Fatty Liver Disease: From Gut Microbiome Alterations to Hepatic Gene Expression

2024-08-27

Abstract excerpt

<title>Abstract</title> <p>Background Non-alcoholic fatty liver disease (NAFLD) is a growing global health problem closely linked to dietary habits, particularly high fructose consumption. This study investigates the combined effects of fructose and common food preservatives (sodium benzoate, sodium nitrite, and potassium sorbate) on the development and progression of NAFLD in a human-microbiota-associated mouse...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 03285733-fe08-596f-b3a4-61ce8db91857
DOI: 10.21203/rs.3.rs-4814043/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Synergistic Effects of Fructose and Food Preservatives on Non-Alcoholic Fatty Liver Disease: From Gut Microbiome Alterations to Hepatic Gene ExpressionDOI 10.21203/rs.3.rs-4814043/v1Read

Bridging the Gut and Liver: Multi-biotics modulate microbiota composition and corroborate transcriptomic improvements in MASLDSemantic proximity Read

Longitudinal analysis of a dietary mouse model of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)Semantic proximity Read

Soluble and insoluble dietary fibres differentially affect liver steatosis and gut microbiota in western-diet fed miceSemantic proximity Read

Identification of biomarkers associated with immune-propionate metabolism in nonalcoholic fatty liver diseaseSemantic proximity Read

The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights.Semantic proximity Read

Probiotic-prebiotic-synbiotic modulation of (YAP1, LATS1 and NF2 mRNAs/miR-1205/lncRNA SRD5A3-AS1) panel in NASH animal modelSemantic proximity Read

Modulation of hepatic mRNA-miRNA panel linked to NAFLD/NASH Hippo signaling and gut microbiota after administration of kefir in Non-Alcoholic Steatohepatitis Rat ModelSemantic proximity Read

From gut to liver: unveiling the differences of intestinal microbiota in NAFL and NASH patientsSemantic proximity Read

Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential for applications in human health and diseaseSemantic proximity Read

Identification and validation of disulfidptosis-associated molecular clusters in non-alcoholic fatty liver diseaseSemantic proximity Read

Establishment of animal models for NASH and utilization for mining associated gut microbiotaSemantic proximity Read

Imbalanced gut microbiota predicts and drives the progression of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in a fast-food diet mouse modelSemantic proximity Read